Medical Care

Global T-Cell Immunotherapy Market Research Report 2025

The global market for T-Cell Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Immunotherapy.
The T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
CAR-T
TCR
TIL Therapies
Segment by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 Market by Application
1.3.1 Global T-Cell Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Immunotherapy Market Perspective (2020-2031)
2.2 Global T-Cell Immunotherapy Growth Trends by Region
2.2.1 Global T-Cell Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 T-Cell Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 T-Cell Immunotherapy Market Dynamics
2.3.1 T-Cell Immunotherapy Industry Trends
2.3.2 T-Cell Immunotherapy Market Drivers
2.3.3 T-Cell Immunotherapy Market Challenges
2.3.4 T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by T-Cell Immunotherapy Revenue
3.4 Global T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2024
3.5 Global Key Players of T-Cell Immunotherapy Head office and Area Served
3.6 Global Key Players of T-Cell Immunotherapy, Product and Application
3.7 Global Key Players of T-Cell Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Immunotherapy Breakdown Data by Type
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031)
5 T-Cell Immunotherapy Breakdown Data by Application
5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2020-2031)
6.2 North America T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America T-Cell Immunotherapy Market Size by Country (2020-2025)
6.4 North America T-Cell Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2020-2031)
7.2 Europe T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe T-Cell Immunotherapy Market Size by Country (2020-2025)
7.4 Europe T-Cell Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific T-Cell Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America T-Cell Immunotherapy Market Size (2020-2031)
9.2 Latin America T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America T-Cell Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America T-Cell Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2020-2025)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2020-2025)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Introduction
11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2020-2025)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2020-2025)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis T-Cell Immunotherapy Introduction
11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Introduction
11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2020-2025)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025)
11.8.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR
Table 4. Key Players of TIL Therapies
Table 5. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global T-Cell Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Market Share by Region (2020-2025)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Market Share by Region (2026-2031)
Table 11. T-Cell Immunotherapy Market Trends
Table 12. T-Cell Immunotherapy Market Drivers
Table 13. T-Cell Immunotherapy Market Challenges
Table 14. T-Cell Immunotherapy Market Restraints
Table 15. Global T-Cell Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global T-Cell Immunotherapy Market Share by Players (2020-2025)
Table 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2024)
Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of T-Cell Immunotherapy, Headquarters and Area Served
Table 21. Global Key Players of T-Cell Immunotherapy, Product and Application
Table 22. Global Key Players of T-Cell Immunotherapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2020-2025)
Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2026-2031)
Table 28. Global T-Cell Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global T-Cell Immunotherapy Revenue Market Share by Application (2020-2025)
Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global T-Cell Immunotherapy Revenue Market Share by Application (2026-2031)
Table 32. North America T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Adaptimmune Company Details
Table 48. Adaptimmune Business Overview
Table 49. Adaptimmune T-Cell Immunotherapy Product
Table 50. Adaptimmune Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 51. Adaptimmune Recent Development
Table 52. Altor Bioscience Corporation Company Details
Table 53. Altor Bioscience Corporation Business Overview
Table 54. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 55. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 56. Altor Bioscience Corporation Recent Development
Table 57. Cellectis Company Details
Table 58. Cellectis Business Overview
Table 59. Cellectis T-Cell Immunotherapy Product
Table 60. Cellectis Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 61. Cellectis Recent Development
Table 62. Juno Therapeutics Company Details
Table 63. Juno Therapeutics Business Overview
Table 64. Juno Therapeutics T-Cell Immunotherapy Product
Table 65. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 66. Juno Therapeutics Recent Development
Table 67. Kite Pharma Company Details
Table 68. Kite Pharma Business Overview
Table 69. Kite Pharma T-Cell Immunotherapy Product
Table 70. Kite Pharma Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 71. Kite Pharma Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis T-Cell Immunotherapy Product
Table 75. Novartis Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Takara Bio Company Details
Table 78. Takara Bio Business Overview
Table 79. Takara Bio T-Cell Immunotherapy Product
Table 80. Takara Bio Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 81. Takara Bio Recent Development
Table 82. Unum Therapeutics Company Details
Table 83. Unum Therapeutics Business Overview
Table 84. Unum Therapeutics T-Cell Immunotherapy Product
Table 85. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)
Table 86. Unum Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report


List of Figures
Figure 1. T-Cell Immunotherapy Picture
Figure 2. Global T-Cell Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global T-Cell Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. CAR-T Features
Figure 5. TCR Features
Figure 6. TIL Therapies Features
Figure 7. Global T-Cell Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global T-Cell Immunotherapy Market Share by Application: 2024 VS 2031
Figure 9. Stomach Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Colorectal Cancer Case Studies
Figure 12. Esophagus Cancer Case Studies
Figure 13. Pancreatic Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. T-Cell Immunotherapy Report Years Considered
Figure 16. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global T-Cell Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global T-Cell Immunotherapy Market Share by Region: 2024 VS 2031
Figure 19. Global T-Cell Immunotherapy Market Share by Players in 2024
Figure 20. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2024
Figure 22. North America T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America T-Cell Immunotherapy Market Share by Country (2020-2031)
Figure 24. United States T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe T-Cell Immunotherapy Market Share by Country (2020-2031)
Figure 28. Germany T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2020-2031)
Figure 36. China T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America T-Cell Immunotherapy Market Share by Country (2020-2031)
Figure 44. Mexico T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa T-Cell Immunotherapy Market Share by Country (2020-2031)
Figure 48. Turkey T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 52. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 53. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 54. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 55. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 57. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 58. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies